Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Icodec vs Glargine in Insulin-Naïve T2D
NCT03751657Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2018
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
A Phase 2 trial of insulin icodec in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Nov 2018; status: completed.
02
Drugs
insulin icodec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03751657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03751657.